Ophthalmic Drugs Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research
According to TechSci Research report, “Global Ophthalmic Drugs Market By Drug Class (Anti-Inflammatory Drugs, Anti-Infection Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others) By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Others) By Product Type (OTC Drugs v/s Prescription Drugs) By Dosage Form (Gels, Ointments, Eye Solutions, Eye Drops, Tablets &Capsules) By Route of Administration (Topical, Ocular, Systemic) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Region, Competition Forecast & Opportunities, 2026”, the global ophthalmic drugs market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of rising number of patients suffering from eye diseases and vision related disorders.
Moreover, the rising number of geriatric population and their tendency to suffer from the eye diseases is further aiding the growth of the market in the next five years. Furthermore, increasing instances of cataract, glaucoma, color blindness, diabetic macular edema, cytomegalovirus retinitis, and age-related macular degeneration are also supporting the market growth.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Ophthalmic Drugs Market"
The global ophthalmic drugs market is segmented by drug class, indication, product type, dosage form, route of administration, distribution channel, competitional landscape, and regional distribution. Based on indication, the market is further bifurcated into dry eye, eye allergy, glaucoma, eye infection, and others. Glaucoma is expected to register largest shares of the market and is anticipated to assert its dominance over the market segment on the account of increasing instances of the disease as well as the large population that is being affected. Moreover, the lifestyle choices and unhealthy food habits has aided to the ever-increasing patient count of diabetes and glaucoma therewith. The factors are intensely responsible for the growth of the market segment.
Based on product type, the market is further divided between, OTC drugs and prescription drugs. Prescription drugs have dominated the historical years and is anticipated to dominate the market in the next five years, on the account of improved safety and efficacy profiles of these drugs. OTC drugs are anticipated to register fastest growing CAGR on the backbone of advantages like easy accessibility to the patient. OTC drug market is largest in the Asia Pacific region and the demand from the region is aiding to the growth of the global market.
Market players with the prescription drugs may suffer a mild restraint due to availability of the OTC drugs. For example, the U.S. FDA has approved Alcon’s Pataday (olopatadine hydrochloride ophthalmic solution 0.7%) for OTC to treat eye allergy. Formerly, it was prescribed under the name of Pazeo. The development of this OTC ophthalmic solution is expected to increase the number of patients for Pataday's product portfolio.
Holding the major shares of the global ophthalmic drugs market are AbbVie Inc. (Allergan), Bausch Health Companies Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Hoya Corporation, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Alcon Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Merck & Co., Inc., Coherus Biosciences, Inc., among others. Market players are actively involved in the research and technological development in the pharmaceuticals and drugs department.
The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through Ophthalmic Drugs. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7633
Customers can also request for 10% free customization on this report.
“Asia Pacific is anticipated to be the most volatile and most promising market in the future five years. Anti-glaucoma and dry eye drugs are rapidly increasing in the region. Large economies like India and China are further aiding the growth of the market in the upcoming five years. Furthermore, rapidly increasing population of middle-class households along with the technological advancements in the medical infrastructures and increasing financial aids for the medical insurances is supporting the growth of the global ophthalmic drug market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Ophthalmic Drugs Market By Drug Class (Anti-Inflammatory Drugs, Anti-Infection Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others) By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Others) By Product Type (OTC Drugs v/s Prescription Drugs) By Dosage Form (Gels, Ointments, Eye Solutions, Eye Drops, Tablets &Capsules) By Route of Administration (Topical, Ocular, Systemic) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global ophthalmic drugs and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global ophthalmic drugs market.
Browse Related Reports:
Global Rare Disease Therapeutics Market By Drug Type (Biologics, Organic Compounds) By Therapeutic Area (Cancer, Blood-related Disorders, Central Nervous System (CNS), Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Disorders, Others) By Route of Administration (Oral, Injectable, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies) By Region, Competition Forecast & Opportunities, 2026
Global Coronavirus Vaccine Market By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026
About TechSci Research:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017
For More Market Research Blogs Visit: https://techsciblog.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ophthalmic Drugs Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research here
News-ID: 2345579 • Views: 332
More Releases from TechSci Research Pvt Ltd
Rack Segment to Dominate the Saudi Arabia Server Market till 2026 | TechSci Rese …
Rise in the number of data centers and development of smart cities is expected to drive the Saudi Arabia server market in the forecast period. According to TechSci Research report, “Saudi Arabia Server Market By Hardware (Rack, Blade, Tower) By Operating System (Linux, Windows, IOS, Others) By Enterprise Size (Small, Medium, Large) By End User (Telecommunication, IT & ITES, Government, BFSI, Others) By Distribution Channel (Reseller, Direct, Systems Integrator, Other), By
Wearable Blankets Market to Grow with An Impressive CAGR During the Forecast Per …
Evolving fashion industry is driving the growth in Global Wearable Blankets Market in the forecast period, 2022-2026. According to TechSci Research report, “Wearable Blankets Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By End User (Adult and Children), By Distribution Channel (Supermarkets/ Hypermarkets, Specialty Stores, Online, Others), By Region”, the global wearable blankets market would potentially project an impressive growth in the forecast period, 2022-2026, with an
Smart Pens Market to Grow with Modernizing Agro-Industry During the Forecast Per …
Advancing technology is driving the growth in Global Smart Pen Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Smart Pen Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Technology (Camera Based, Accelerometer Based, trackball Based, Active Based and Others), By End Use (BFSI, Healthcare, Government, IT & Telecom, and Others), By Sales Channel (Electronic Stores, Supermarkets/hypermarkets, Online, Others), By Region”, the global
Global Fem Work Desk Market to be Dominated by Residential End Use Segment till …
Increasing adoption of ergonomic furniture and adoption of advanced solutions in official spaces is expected to drive the demand of global fem work desk market in the forecast period. According to TechSci Research report, “Fem Work Desk Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Product Type (Manual Adjustable, Electrically Adjustable), By End Use (Residential, Offices, Healthcare, Institutional, Others), By Sales Channel (Specialty Stores, Supermarkets/hypermarkets, Online
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market. Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug